Atar Shaul, Rosenschein Uri
Ha'Emek Medical Center, Afula, Israel.
J Thromb Thrombolysis. 2004 Apr;17(2):107-14. doi: 10.1023/B:THRO.0000037665.21691.61.
Reperfusion strategies in acute myocardial infarction and thrombotic vascular occlusion are focused on rapid and complete restoration of antegrade flow in the infarct-related artery in order to maximize myocardial salvage. Due to the limitations of fibrinolytic agents in restoration of vascular flow, ultrasonic clot dissolution alone and concomitantly with fibrinolytic, anti-thrombotic and echocardiographic contrast agents has been intensively studied during the last 2 decades. Ultrasound thrombolysis has been tested in-vitro and in-vivo as well as in patients with acute thrombotic occlusions. We review currently available techniques and methods of ultrasonic thrombolysis and present recent clinical and experimental data. The future role of ultrasonic thrombolysis and the strategy of "power thrombectomy" for treatment of acute coronary syndromes is also discussed.
急性心肌梗死和血栓性血管闭塞的再灌注策略着重于迅速且完全地恢复梗死相关动脉的顺行血流,以最大限度地挽救心肌。由于纤维蛋白溶解剂在恢复血管血流方面存在局限性,在过去20年中,单独使用超声溶解血栓以及同时联合使用纤维蛋白溶解剂、抗血栓药物和超声心动图造影剂的方法得到了深入研究。超声溶栓已在体外、体内以及急性血栓闭塞患者中进行了测试。我们回顾了目前可用的超声溶栓技术和方法,并展示了近期的临床和实验数据。还讨论了超声溶栓在未来的作用以及“强力血栓切除术”治疗急性冠脉综合征的策略。